2025-05-13 - Analysis Report
Okay, here's a report analyzing Chevron Corp (CVX) based on the provided data, structured as requested:

## Chevron Corp (CVX) Analysis

Chevron Corp is one of the world's leading integrated energy companies.

### 1. Performance vs. S&P 500 (VOO)

*   **CVX Cumulative Return:** 51.36%
*   **VOO Cumulative Return:** 93.97%
*   **Absolute Divergence (CVX - VOO):** -42.6%
*   **Divergence Range (Max: 67.6, Min: -72.8):**
*   **Relative Divergence:** 21.5

**Analysis:**  CVX has significantly underperformed the S&P 500 (VOO) over the tracked period.  The -42.6% absolute divergence indicates a substantial difference in cumulative returns. A relative divergence of 21.5 suggests that CVX's underperformance is positioned in the lower quartile compared to its historical divergence range with VOO.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha  | Beta  | Cap(B) |
|------------|---------|---------|--------|-------|--------|
| 2015-2017  | 42.0%   | 5.4%    | 10.0%  | 0.2   | 158.9  |
| 2016-2018  | 32.0%   | 66.1%   | 10.0%  | 0.9   | 143.4  |
| 2017-2019  | 15.0%   | 66.1%   | -19.0% | 0.7   | 165.3  |
| 2018-2020  | -31.0%  | 66.1%   | -62.0% | -0.0  | 122.4  |
| 2019-2021  | 19.0%   | 60.1%   | -42.0% | -0.2  | 179.0  |
| 2020-2022  | 98.0%   | 74.9%   | 89.0%  | -0.3  | 283.7  |
| 2021-2023  | 81.0%   | 74.9%   | 60.0%  | 0.6   | 245.0  |
| 2022-2024  | 12.0%   | 74.9%   | -8.0%  | 0.3   | 248.1  |
| 2023-2025  | -57.0%  | 74.4%   | -89.0% | 0.7   | 245.3  |

**Analysis:** This table presents a mixed picture. We can observe:

*   **Volatility:** The MDD (Maximum Drawdown) values are significant in several periods, indicating substantial price declines.
*   **Inconsistent Alpha:** Alpha, representing excess return over the benchmark, varies considerably. Some periods show positive alpha, while others show significant negative alpha.
*   **Beta Fluctuations:** Beta values fluctuate, indicating varying degrees of correlation with the market. Periods with negative Beta suggest inverse correlation.
*   **Growth and Decline:** CAGR (Compound Annual Growth Rate) shows periods of strong growth and substantial decline.

### 2. Recent Stock Price Movements

*   **Current Price:** 141.62
*   **Previous Close:** 138.49
*   **Change:** 2.26
*   **5-Day Moving Average:** 137.71
*   **20-Day Moving Average:** 137.14
*   **60-Day Moving Average:** 149.87

**Analysis:**  The stock price has increased significantly since the previous close (Change = 2.26), indicating a recent upward swing.  The 5-day and 20-day moving averages are below the current price, suggesting short-term upward momentum. However, the 60-day moving average is significantly higher, indicating that the current price is still below its medium-term trend.

### 3. Indicators & Expected Return

*   **Market Risk Indicator (MRI):** 0.3676 (Low Risk)
*   **RSI:** 60.63
*   **PPO:** 0.7451
*   **Recent (20-day) Relative Divergence Change:** 0.1 (Positive - Short-term increase)
*   **Expected Return:** 59.5% (Long-term, vs. S&P 500)

**Analysis:**

*   The MRI suggests a **low-risk** market environment.
*   RSI is at 60.63, nearing the overbought level (typically above 70).
*   PPO being positive implies the 20-day moving average is above the 50-day moving average, confirming the upward trend suggested by the moving averages in Section 2.
*   The recent positive change in relative divergence aligns with the recent price increase.
*   The expected return of 59.5% is a positive signal for long-term investors.

**Recent Price Surge:** The significant change of 2.26 from the previous close likely reflects recent news, earnings, or other events impacting the stock.

### 4. Recent News & Significant Events

*   **2025-05-09:** Major business developments, regulatory changes, or market events.
*   **2025-05-11:** Analyst discussions regarding recent performance and outlook.
*   **2025-05-10:** Stock volatility influenced by recent news, earnings, or executive actions.
*   **2025-05-12:** Expert advice to monitor recent news and company announcements.

**Analysis:** The news snippets highlight recent significant events that are impacting CVX's stock. The volatility and analyst discussions suggest a period of heightened uncertainty and active evaluation of the company. Investors should stay informed about specific details of these events.

### 5. Recent Earnings Analysis

| Date       | EPS  | Revenue        |
|------------|------|----------------|
| 2025-05-08 | 2.01 | 46.10 B$       |
| 2024-11-07 | 2.49 | 48.93 B$       |
| 2024-08-07 | 2.43 | 49.57 B$       |
| 2024-05-02 | 2.99 | 46.58 B$       |
| 2025-05-08 | 2.99 | 46.58 B$       |

**Analysis:**  The table shows a recent earnings report on 2025-05-08 with an EPS of 2.01 and revenue of 46.10 B$. Prior to that, there was a gradual decline in EPS and revenue over the past few quarters. The duplicate entry for 2025-05-08 with EPS of 2.99 might be an error or a revision.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue     | Profit Margin |
|------------|-------------|---------------|
| 2025-03-31 | $46.10B     | 29.00%        |
| 2024-12-31 | $48.33B     | 27.34%        |
| 2024-09-30 | $48.93B     | 29.15%        |
| 2024-06-30 | $49.57B     | 29.66%        |
| 2024-03-31 | $46.58B     | 31.66%        |

**Capital and Profitability:**

| Quarter    | Equity       | ROE    |
|------------|--------------|--------|
| 2025-03-31 | $149.24B     | 2.35%  |
| 2024-12-31 | $152.32B     | 2.13%  |
| 2024-09-30 | $156.20B     | 2.87%  |
| 2024-06-30 | $159.23B     | 2.78%  |
| 2024-03-31 | $160.62B     | 3.42%  |

**Analysis:**

*   **Revenue & Profitability:** Revenue has shown a slight decline from mid-2024 to early 2025, accompanied by a decrease in profit margin.
*   **Capital & Profitability:** Equity has decreased, indicating a potential return of capital to shareholders or investment losses. ROE has also decreased.

### 7. Overall Analysis

Chevron (CVX) presents a mixed investment picture. While the MRI suggests a low-risk market environment and a high expected return over the long term, CVX has significantly underperformed the S&P 500. Recent earnings and revenue have declined, equity has decreased, and recent news highlights market volatility and analyst uncertainty. Recent price action is positive.

**Recommendation:**  Due to the recent negative events and relative underperformance, investors should carefully consider their risk tolerance and investment horizon before committing to CVX. Monitor upcoming earnings releases, major business development announcements, and analyst opinions. Further due diligence is required to determine whether the recent price increase is sustainable and if the long-term expected return is realistic.
